Etrasimod as Prevention of Pouchitis | MicrobiomeTrials← Back to trialsNCT07486921
Etrasimod as Prevention of Pouchitis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-06-12Est. Completion: 2030-02-06
Enrollment target: 40 participants Locations- Icahn School Of Medicine at Mount Sinai, New York, New York, United States
Other microbiome trials you might be interested in
Ulcerative ColitisIleal Pouch
Ulcerative colitis (UC) is a disease that causes long-term inflammation in the digestive tract, and many people with thi…
Ann Arbor, United StatesEst. completion May 2029
Pouchitis
This clinical trial is to evaluate investigational compound CLF065 as a treatment for adult patients with chronic pouchi…
La Jolla, United StatesEst. completion Mar 2027